1. Home
  2. EEIQ vs NXL Comparison

EEIQ vs NXL Comparison

Compare EEIQ & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EpicQuest Education Group International Limited

EEIQ

EpicQuest Education Group International Limited

HOLD

Current Price

$3.11

Market Cap

7.8M

Sector

Real Estate

ML Signal

HOLD

Logo Nexalin Technology Inc.

NXL

Nexalin Technology Inc.

SELL

Current Price

$1.37

Market Cap

7.5M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
EEIQ
NXL
Founded
2017
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medical Specialities
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.8M
7.5M
IPO Year
2019
2022

Fundamental Metrics

Financial Performance
Metric
EEIQ
NXL
Price
$3.11
$1.37
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
6.0K
★ 19.7K
Earning Date
06-25-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 39.76
EPS
★ N/A
N/A
Revenue
N/A
★ $301,647.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$76.04
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 78.78
52 Week Low
$0.15
$0.22
52 Week High
$12.70
$67.20

Technical Indicators

Market Signals
Indicator
EEIQ
NXL
Relative Strength Index (RSI) 28.64 30.47
Support Level $2.85 $1.31
Resistance Level $3.82 $5.36
Average True Range (ATR) 0.22 0.15
MACD -0.09 0.13
Stochastic Oscillator 20.15 10.00

Price Performance

Historical Comparison
EEIQ
NXL

About EEIQ EpicQuest Education Group International Limited

EpicQuest Education Group International Ltd provides comprehensive education solutions for domestic and international students interested in university and college degree programs in the U.S, Canada, and the UK. In addition, the company has a recruiting relationship with the regional campuses of Miami University of Ohio, where it maintains residential facilities, a full-service cafeteria, recreational facilities, shuttle buses, and an office for the regional campuses that provides study abroad and post-study services for its students; these facilities are not owned, maintained, operated or are part of Miami University. The Company's revenue is derived from foreign education programs, university education programs and student accommodation services.

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The Company has developed the Generation 1 (Gen 1) medical device, a cranial electrotherapy stimulation (CES) device classified by the U.S. Food and Drug Administration (FDA) as a Class II device. The Company operates as a single operating and reportable segment, focused on the design and development of innovative neurostimulation products. The Company focuses on treating mental health conditions without reliance on drugs or psychotherapy. Geographically, it generates sales in the USA and China, with China generating the maximum sales.

Share on Social Networks: